NoteAbsence of Influence of Concomitant Administration of Rabeprazole on the Pharmacokinetics of Tacrolimus in Adult Living-donor Liver Transplant Patients: A Case–control Study
References (24)
- et al.
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes
Biochem. Pharmacol.
(1994) - et al.
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
J. Biol. Chem.
(1994) - et al.
Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5
Drug Metab. Pharmacokinet.
(2008) - et al.
Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study
Clin. Transplant.
(2002) - et al.
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
Clin. Pharmacol. Ther.
(2003) - et al.
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus
Clin. Chem.
(2005) - et al.
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro
Drug Metab. Dispos.
(2006) Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole
Clin. Pharmacokinet.
(1996)- et al.
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation
Transplantation.
(2002) - et al.
Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism
Ann. Pharmacother.
(2004)
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
Biopharm. Drug Dispos.
(2007)
Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients
Drug Metab. Dispos.
(2009)
Cited by (13)
Chronic kidney disease and gastrointestinal system disturbances
2023, Advances in Health and DiseaseEffect of proton pump inhibitors on tacrolimus blood concentration in organ transplant recipients
2019, Journal of International Pharmaceutical Research
This work was supported in part by the 21 st Century Center of Excellence (COE) Program "Knowledge Information Infrastructure for Genome Science'' by a grant-in-Aid from the Japan Health Sciences Foundation for "Research on Health Sciences Focusing on Drug Innovation'', and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. K. H. was supported as a Research Assistant by the 21st Century COE program "Knowledge Information Infrastructure for Genome Science”
Copyright © 2009 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.